ESR1 and breast carcinoma: We found that estrogen induced the activation of the PI3K/AKT/GSK3β/β-catenin signaling pathway in ER-positive breast cancer stem/progenitor cells, which was attenuated by the AKT inhibitor (Figure 6A).